Evidence map›Paper›PMID 20736996›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2010

Disulfiram attenuates drug-primed reinstatement of cocaine seeking via inhibition of dopamine β-hydroxylase.

Jason P Schroeder, Debra A Cooper, Jesse R Schank, Megan A Lyle, Meriem Gaval-Cruz, Yvonne E Ogbonmwan, Nikita Pozdeyev, Kimberly G Freeman, P Michael Iuvone, Gaylen L Edwards and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 122 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Assessment of safety, cardiovascular and subjective effects after intravenous cocaine and lofexidine.Progress in neuro-psychopharmacology & biological psychiatry · 2014
    Trial
  6. Pharmacogenetic randomized trial for cocaine abuse: disulfiram and α1A-adrenoceptor gene variation.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2013
    Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Review
  14. Exposure to disulfiram and incidence of parkinsonism.Journal of occupational medicine and toxicology (London, England) · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Disulfiram: Mechanisms, Applications, and Challenges.Antibiotics (Basel, Switzerland) · 2023
    Review

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Jason P SchroederDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Debra A Cooper
Jesse R Schank
Megan A Lyle
Meriem Gaval-Cruz
Yvonne E Ogbonmwan
Nikita Pozdeyev
Kimberly G Freeman
P Michael Iuvone
Gaylen L Edwards
Philip V Holmes
David Weinshenker
Emory University · USUniversity of Georgia · US

Funding

P30-Core Grant for Vision Research Core CP30EY006360 · NEI · EMORY UNIVERSITY · PI GEISERT, ELDON E · 1986 to 2025
$15.3M
Neuromodulators and Circadian Clocks: Roles in Retinal Function and DysfunctionR01EY004864 · NEI · EMORY UNIVERSITY · PI IUVONE, P MICHAEL · 1985 to 2018
$7.0M
Training Program in Neurobiology of Drug AbuseT32DA015040 · NIDA · EMORY UNIVERSITY · PI KUHAR, MICHAEL J · 2003 to 2012
$3.6M
Effects of voluntary exercise on reinstatement of cocaine seekingR01DA027535 · NIDA · EMORY UNIVERSITY · PI HOLMES, PHILIP V, WEINSHENKER, DAVID · 2010 to 2014
$1.9M
Mechanism of Disulfiram-Induced Cocaine AbstinenceR01DA017963 · NIDA · EMORY UNIVERSITY · PI WEINSHENKER, DAVID · 2006 to 2009
$1.3M
Identification of mechanisms underlying reduction of cocaine seeking by exerciseF31DA033091 · NIDA · EMORY UNIVERSITY · PI OGBONMWAN, YVONNE ENIYE · 2012 to 2014
$88k
Modulators of behavioral hypersensitivity to cocaine following DBH inhibitionF31DA025040 · NIDA · EMORY UNIVERSITY · PI GAVAL CRUZ, MERIEM · 2008 to 2010
$83k
Dopamine Beta-hydroxylase and Responses to CocaineF31DA019746 · NIDA · EMORY UNIVERSITY · PI SCHANK, JESSE R · 2006 to 2008
$81k
NEI NIH HHS EY004864NEI NIH HHS P30 EY006360NEI NIH HHS P30 EY06360NEI NIH HHS R01 EY004864NIDA NIH HHS DA015040NIDA NIH HHS DA017963NIDA NIH HHS DA019746NIDA NIH HHS DA027535NIDA NIH HHS DA25040NIDA NIH HHS F31 DA019746NIDA NIH HHS F31 DA025040NIDA NIH HHS F31 DA033091NIDA NIH HHS R01 DA017963NIDA NIH HHS R01 DA027535NIDA NIH HHS T32 DA015040
6 · The paper itself

Abstract

The antialcoholism medication disulfiram (Antabuse) inhibits aldehyde dehydrogenase (ALDH), which results in the accumulation of acetaldehyde upon ethanol ingestion and produces the aversive 'Antabuse reaction' that deters alcohol consumption. Disulfiram has also been shown to deter cocaine use, even in the absence of an interaction with alcohol, indicating the existence of an ALDH-independent therapeutic mechanism. We hypothesized that disulfiram's inhibition of dopamine β-hydroxylase (DBH), the catecholamine biosynthetic enzyme that converts dopamine (DA) to norepinephrine (NE) in noradrenergic neurons, underlies the drug's ability to treat cocaine dependence. We tested the effects of disulfiram on cocaine and food self-administration behavior and drug-primed reinstatement of cocaine seeking in rats. We then compared the effects of disulfiram with those of the selective DBH inhibitor, nepicastat. Disulfiram, at a dose (100 mg/kg, i.p.) that reduced brain NE by ∼40%, did not alter the response for food or cocaine on a fixed ratio 1 schedule, whereas it completely blocked cocaine-primed (10 mg/kg, i.p.) reinstatement of drug seeking following extinction. A lower dose of disulfiram (10 mg/kg) that did not reduce NE had no effect on cocaine-primed reinstatement. Nepicastat recapitulated the behavioral effects of disulfiram (100 mg/kg) at a dose (50 mg/kg, i.p.) that produced a similar reduction in brain NE. Food-primed reinstatement of food seeking was not impaired by DBH inhibition. Our results suggest that disulfiram's efficacy in the treatment of cocaine addiction is associated with the inhibition of DBH and interference with the ability of environmental stimuli to trigger relapse.

Indexed as

Alcohol DeterrentsAnimalsBrainCocaineConditioning, OperantDisulfiramDopamineDopamine beta-HydroxylaseDrug InteractionsExtinction, PsychologicalFoodImidazolesMaleNorepinephrineRatsRats, Sprague-DawleyAlcohol DeterrentsCocaineDisulfiramDopamineDopamine beta-HydroxylaseImidazolesnepicastatNorepinephrineThiones

Identifiers

PMID20736996
PMCPMC2956132
OpenAlexW1999847083

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.